By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters today announced that its board has approved a plan to repurchase up to $500 million of its outstanding common shares over the next 24 months.

The board gave its approval on Wednesday. Purchases will be made through open market transactions. The company recently completed a $500 million stock repurchase program that was announced in February 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.